JBHTNEUTRAL

JBHT EV/EBITDA Analysis

15.4x

Updated 1323h ago·SEC filings & market data

Key Takeaway

JBHT trades at 16.7x EV/EBITDA, where EV/EBITDA measures a company's total value relative to its cash operating earnings.

Sector Performance

58th percentile

JBHT

15.4x

Sector Median

13.6x

Sector Avg

-29.8x

Prior Period

16.7x(Aug 2026)

↑ Improving
📊

Deep Analysis

JBHT trades at 16.7x EV/EBITDA, where EV/EBITDA measures a company's total value relative to its cash operating earnings.

That is above the sector median of 13.5x, placing JBHT in the 63rd percentile among peers, so the market assigns it a premium valuation. The metric is stable over the last eight quarters: year-over-year change is not available, while the quarter-over-quarter move is +3.7% from 16.1x. The combination of a level above peers and a stable trend suggests a mildly priced-in expectation rather than an expanding speculative gap. For investors, this means limited upside from multiple re-rating, but also no immediate compression pressure. This supports the overall NEUTRAL verdict because the valuation is neither cheap enough to signal opportunity nor stretched enough to be a clear risk.

Frequently Asked Questions

What does the EV/EBITDA tell investors about JBHT?

A valuation multiple preferred by analysts for capital-intensive or leveraged businesses. Useful for cross-sector comparisons where earnings can be distorted by debt.

How is the EV/EBITDA calculated?

EV/EBITDA is calculated as: Enterprise Value / EBITDA.

The Formula

Enterprise Value / EBITDA

Why It Matters

A valuation multiple preferred by analysts for capital-intensive or leveraged businesses. Useful for cross-sector comparisons where earnings can be distorted by debt.

Advertisement

Master JBHT's Valuation

Get the complete institutional research report covering all fundamental and technical metrics.

View full JBHT research report →

Free account — no credit card

JBHT

15.4x

Sector Median

13.6x

Sector Avg

-29.8x

How JBHT's EV/EBITDA compares to sector peers.

Not financial advice. Research tool only. Data may be delayed.